SPRB — Spruce Biosciences Share News
0.000.00%
Last trade - 00:00Brief: Spruce Biosciences Reports Third Quarter 2022 Financial Results, Provides Corporate Updates
Brief: Spruce Biosciences Inc - QTRLY Loss Per Share $0.51
Spruce Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Spruce Biosciences Inc reports results for the quarter ended in March - Earnings Summary
Brief: Spruce Biosciences Reports First Quarter 2022 Results
Spruce Biosciences Inc expected to post a loss of 46 cents a share - Earnings Preview
Brief: Spruce Biosciences Appoints Libbie Mansell As Chief Regulatory And Quality Officer
Brief: Spruce Biosciences Reports Fourth Quarter And Full Year 2021 Financial Results
Brief: Spruce Biosciences Inc Says May Offer And Sell Shares Of Our Common Stock Having An Aggregate Offering Price Of Up To $21.0 Million From Time To Time
Brief: Spruce Biosciences Provides Clinical Program Updates And Outlook For 2022
Brief: Spruce Biosciences Files For Mixed Shelf Of Up To $200 Mln
U.S. STOCKS ON THE MOVE-Apple, Flotek Industries, Tesla
U.S. RESEARCH ROUNDUP- Bank of America, Everbridge, Synopsys
Spruce Biosciences Inc reports results for the quarter ended in September - Earnings Summary
Brief: Spruce Biosciences Appoints Mike Grey As Interim CEO
Brief: Spruce Biosciences Reports Third Quarter 2021 Financial Results And Provides Corporate Updates
Spruce Biosciences Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Spruce Biosciences Announces Pediatric Classic CAH Program Details During Virtual Research And Development Day
Spruce Biosciences Inc reports results for the quarter ended in June - Earnings Summary